Join to View Full Profile
1500 E. Duarte RoadDuarte, CA 91010
Dr. Villaflor is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Rush University Medical CenterFellowship, Hematology and Medical Oncology, 2001 - 2004- Rush University Medical CenterResidency, Internal Medicine, 1998 - 2001
Rush Medical College of Rush University Medical CenterClass of 1998
Certifications & Licensure
CA State Medical License 2020 - 2026
IL State Medical License 1998 - 2026
American Board of Internal Medicine Medical Oncology
Clinical Trials
- INBRX-106 in Combination With Pembrolizumab in First-line PD-L1 CPS≥20 HNSCC Start of enrollment: 2024 May 14
- A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC) Start of enrollment: 2024 Aug 01
- Combination Trial of Tipifarnib and Alpelisib in Adult Recurrent/ Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC) Start of enrollment: 2021 Dec 07
- Join now to see all
Publications & Presentations
PubMed
- Phase II Study of Nivolumab and Ipilimumab for Treatment of Metastatic/Recurrent Adenoid Cystic Carcinoma (ACC) of all Anatomic Sites of Origin and Other Malignant Sal...Young Kwang Chae, Richard Duan, Liam Il-Young Chung, Youjin Oh, Borislav Alexiev
Cancer Medicine. 2025-04-01 - Barriers to and enablers of physical activity participation in lung cancer survivors.Julia Fram, Kathleen Boss, Victoria Villaflor, Prakash Jayabalan
PM & R. 2024-12-01 - 1 citationsGenomic and molecular alterations associated with primary resistance to immune checkpoint inhibitors.Jyoti Malhotra, Subhajyoti De, Kim Nguyen, Percy Lee, Victoria Villaflor
Cancer Immunology, Immunotherapy. 2024-09-13
Journal Articles
- Association of Tumor Mutational Burden with DNA Repair Mutations and Response to Anti-PD-1/PD-L1 Therapy in Non-Small Cell Lung CancerNisha Mohindra, Victoria Villaflor, Clinical Lung Cancer
Authored Content
- Association of Tumor Mutational Burden with DNA Repair Mutations and Response to Anti-PD-1/PD-L1 Therapy in Non-Small Cell Lung CancerSeptember 2018
Press Mentions
Radical Therapy for Stage III NSCLC: Practical Advice to ConsiderMay 7th, 2021
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
